risperidone has been researched along with Child Mental Disorders in 5 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In children and adolescents treated with risperidone, hyperprolactinemia is a frequent complication that may have clinical repercussions." | 7.81 | Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects. ( Celeri, EH; Dalgalarrondo, P; de Mello, MP; Della Torre, OH; dos Santos Júnior, A; Ferreira Neto, AP; Fontana, TS; Guerra Júnior, G; Henriques, TB; Paes, LA; Sewaybricker, LE, 2015) |
| "In children and adolescents treated with risperidone, hyperprolactinemia is a frequent complication that may have clinical repercussions." | 3.81 | Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects. ( Celeri, EH; Dalgalarrondo, P; de Mello, MP; Della Torre, OH; dos Santos Júnior, A; Ferreira Neto, AP; Fontana, TS; Guerra Júnior, G; Henriques, TB; Paes, LA; Sewaybricker, LE, 2015) |
| " The use of antipsychotics is associated with a number of adverse effects for which routine monitoring is recommended." | 1.48 | Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada. ( Cepoiu-Martin, M; Chen, W; Cooke, L; Duncan, D; Pringsheim, T; Stang, A; Symonds, C, 2018) |
| "Risperidone-treated children and adolescents were assessed for CHRNA7 copy number state using droplet digital PCR and genomic quantitative PCR." | 1.46 | CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents. ( Calarge, CA; Gillentine, MA; Grochowski, CM; Lupski, JR; Schaaf, CP; White, JJ, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scarborough, J | 1 |
| Mueller, F | 1 |
| Arban, R | 1 |
| Dorner-Ciossek, C | 1 |
| Weber-Stadlbauer, U | 1 |
| Rosenbrock, H | 1 |
| Meyer, U | 1 |
| Richetto, J | 1 |
| Dhindsa, RS | 1 |
| Zoghbi, AW | 1 |
| Krizay, DK | 1 |
| Vasavda, C | 1 |
| Goldstein, DB | 1 |
| Gillentine, MA | 1 |
| White, JJ | 1 |
| Grochowski, CM | 1 |
| Lupski, JR | 1 |
| Schaaf, CP | 1 |
| Calarge, CA | 1 |
| Chen, W | 1 |
| Cepoiu-Martin, M | 1 |
| Stang, A | 1 |
| Duncan, D | 1 |
| Symonds, C | 1 |
| Cooke, L | 1 |
| Pringsheim, T | 1 |
| dos Santos Júnior, A | 1 |
| Henriques, TB | 1 |
| de Mello, MP | 1 |
| Ferreira Neto, AP | 1 |
| Paes, LA | 1 |
| Della Torre, OH | 1 |
| Sewaybricker, LE | 1 |
| Fontana, TS | 1 |
| Celeri, EH | 1 |
| Guerra Júnior, G | 1 |
| Dalgalarrondo, P | 1 |
5 other studies available for risperidone and Child Mental Disorders
| Article | Year |
|---|---|
Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Mice; Neurodevelopmental Disorders; Pharmaceuti | 2020 |
A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Antipsycho | 2021 |
CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents.
Topics: Adolescent; alpha7 Nicotinic Acetylcholine Receptor; Antipsychotic Agents; Child; Cohort Studies; Fe | 2017 |
Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.
Topics: Adolescent; Alberta; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Chi | 2018 |
Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects.
Topics: Adolescent; Alleles; Antipsychotic Agents; Child; Cross-Sectional Studies; Female; Genetic Predispos | 2015 |